Naltrexone for Overdose Prevention — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Naltrexone for Overdose Prevention — Stella

Home/Overdose Accidental/

View on ClinicalTrials.gov

Recruiting

Back to Overdose Accidental trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Center on Substance Use and Health, San Francisco, California

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

University of California, San Francisco

Collaborators

National Institute on Drug Abuse (NIDA)

Enrollment target

~100 participants

Started

April 2025

Primary completion

April 2027

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.